SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples quarterly results beat expectations, but shares drew a muted-to-negative reaction as traders debated whether the results and outlook justified the stocks high valuation. Concerns centered on rising memory costs and margin pressure, along with weaker China, iPad, and wearables results; bulls pointed to strong iPhone and Mac sales and the overall earnings beat.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs quarterly results beat expectations and its raised outlook highlighted rapid AI-driven commercial growth, including commercial revenue surpassing government revenue for the first time. Traders are divided over the weak share-price reaction: bulls point to strong execution, while skeptics cite the stocks rich valuation and broader pressure on AI and technology shares.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs Phase 3 REGAL trial reaching its prespecified 80th event triggered final analysis, putting the pending GPS topline results at the center of discussion. Traders disagree over the sharp selloff: some see profit-taking and risk reduction ahead of a binary readout, while others speculate about a negative data leak or blame short pressure; neither explanation is confirmed.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs quarterly earnings report is the dominant focus, with Intels disappointing results and a broader semiconductor selloff intensifying scrutiny of AMDs outlook. Traders are divided between fears that lofty expectations and weak guidance could deepen the decline and hopes that strong results will show AMDs growth story is distinct from Intels troubles.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles planned stock and bond offerings to fund its AI and data-center expansion are driving the selloff, with traders worried about dilution, debt and whether the spending will generate returns. Some argue the financing was disclosed in advance and caps future fundraising, while others see the timing as a warning about balance-sheet risk.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehrs fiscal Q1 report beat expectations and raised its FY27 revenue outlook, reinforcing the AI chip-testing growth story. Traders welcomed the results but debated the stocks steep decline despite the strong report, citing valuation concerns and broader market weakness.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

A report that nonprofit Usona has filed an FDA application for psilocybin in major depressive disorder has raised fears of a competitive lead over Compass, whose COMP360 program targets treatment-resistant depression; some traders question whether the report is confirmed and argue the indications and commercial prospects differ. The selloff has also sharpened calls for management to clarify Compasss own NDA timeline.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Emergents Q3 results and lower full-year outlook are driving discussion, with traders focused on falling revenue, weak NARCAN sales, and uncertain timing of government orders. Many are frustrated by repeated forecast cuts and worry about debt and refinancing, while some see potential in cost savings and future CYFENDUS procurement.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is under pressure amid a broad technology selloff, with traders questioning whether heavy AI and data-center spending can generate adequate returns and pointing to weak reactions around megacap earnings. The community is divided between expecting further declines and looking for a bounce near technical support; election and geopolitical uncertainty are also mentioned as headwinds.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A sharp selloff in semiconductor and tech stocks, amid worries that AI spending and chip demand may not justify valuations, has driven attention to SOXL; weakness in major chip holdings and broader risk-off trading are adding pressure. Traders are split between buying the steep dip for a rebound and warning that further declines and leverage decay could deepen losses.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ABCL 

🔥Jp Morgan, UBS, and Goldman target prices for $ABCL: $18, $17, and $13 and Jefferies at $21. 

🙌 Today you have the chance to buy at $11.X

Close to the same price at which Andrew Booth bought 37,200 shares, Michael Hayden bought over $1M worth, and John Montalbano another $110K 🤓

💡When the CFO and several board members buy over $1.5M out of their own pockets after learning about some spectacular clinical data, and the market gives you the chance to fish in the same river...

You guys decide for yourselves...

Stonk Trades

XxZeeMoneyxX

Ckkung71

StockTwits for iOS

AbCellera Biologics Inc

 

🔥Jp Morgan, UBS, and Goldman target prices for 

: $18, $17, and $13 and Jefferies at $21. 

🙌 Today you have the chance to buy at $11.X

Close to the same price at which Andrew Booth bought 37,200 shares, Michael Hayden bought over $1M worth, and John Montalbano another $110K 🤓

💡When the CFO and several board members buy over $1.5M out of their own pockets after learning about some spectacular clinical data, and the market gives you the chance to fish in the same river...

You guys decide for yourselves...